Purple Biotech (PPBT) Change in Acquisitions & Divestments (2017 - 2026)
Purple Biotech's (PPBT) quarterly Change in Acquisitions & Divestments came in at $2000.0 in Q1 2026, little changed year-on-year from $2000.0 in Q1 2025, and down 60.0% on a QoQ basis from $5000.0 in Q4 2025.
Purple Biotech (PPBT) Change in Acquisitions & Divestments (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $2000.0 in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments changed 0.0% year-over-year to $2000.0 in Q1 2026; TTM through Mar 2026 was -$9000.0, a 28.57% decrease from a year earlier, with the FY2025 full-year figure at -$9000.0, down 550.0% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $2000.0, down from $5000.0 in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for PPBT reached as high as $22.1 million in Q4 2022 and fell as low as -$16.8 million in Q3 2022.
- Historically, Change in Acquisitions & Divestments has averaged $2.5 million across 5 years, with a median of $2000.0 in 2025.
- Across the five-year window, Change in Acquisitions & Divestments plunged 1298.64% in 2022 and soared 100.05% in 2023, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $22.1 million in 2022, then slumped by 100.03% to -$6000.0 in 2023, then soared by 50.0% to -$3000.0 in 2024, then jumped by 266.67% to $5000.0 in 2025, then slumped by 60.0% to $2000.0 in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $2000.0 in Q1 2026, $5000.0 in Q4 2025, and -$5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn |
| 10 | Purple Biotech | 1.34 Bn | 1.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 15.80 Mn |
| Mar 31, 2023 | 15.80 Mn |